drugset / Trial / NCT00284739
Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Intracavitary injection of low dose alteplase into loculated abdominopelvic abscesses will reduce the duration of percutaneous drainage and increase the proportion of successful drainages.
Timeline
- Start
- 2006-02
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alteplase | Protein / enzyme biologic | 2 mg | Other |
| Subject | Alteplase | Protein / enzyme biologic | 4 mg | Other |